Skip to content
10-Q

Quarterly Report

Protara Therapeutics, Inc. TARA

0001213900-25-107881

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 38.59M sh
Shares Diluted Q3 2025 · Sep 30, 2025 42.27M sh
Shares Diluted Q3 2025 · Sep 30, 2025 41.76M sh
Shares Diluted Q3 2025 · Sep 30, 2024 22.33M sh
Shares Diluted Q3 2025 · Sep 30, 2024 18.34M sh
Capex Q3 2025 · Sep 30, 2025 $70K
Capex Q3 2025 · Sep 30, 2024 $63K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$39.42M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$26.5M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $12.55M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $162.8M
Stockholders Equity Q3 2025 · Sep 30, 2025 $132.29M
Stockholders Equity Q3 2025 · Jun 30, 2025 $144.42M
Stockholders Equity Q3 2025 · Mar 31, 2025 $158.48M
Stockholders Equity Q3 2025 · Dec 31, 2024 $167.13M
Stockholders Equity Q3 2025 · Sep 30, 2024 $81.79M
Stockholders Equity Q3 2025 · Jun 30, 2024 $92.05M
Stockholders Equity Q3 2025 · Mar 31, 2024 $58.41M
Stockholders Equity Q3 2025 · Dec 31, 2023 $68.32M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.91M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.96M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.35M
Total Liabilities Q3 2025 · Dec 31, 2024 $14.32M
Current Assets Q3 2025 · Sep 30, 2025 $135.64M
Current Assets Q3 2025 · Dec 31, 2024 $172.16M
Total Assets Q3 2025 · Sep 30, 2025 $144.64M
Total Assets Q3 2025 · Dec 31, 2024 $181.45M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.96
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.74
Eps Basic Q3 2025 · Sep 30, 2025 −$0.31
Eps Basic Q3 2025 · Sep 30, 2025 −$0.96
Eps Basic Q3 2025 · Sep 30, 2024 −$0.50
Eps Basic Q3 2025 · Sep 30, 2024 −$1.74
Sga Expense Q3 2025 · Sep 30, 2025 $5.17M
Sga Expense Q3 2025 · Sep 30, 2025 $15.96M
Sga Expense Q3 2025 · Sep 30, 2024 $4.26M
Sga Expense Q3 2025 · Sep 30, 2024 $12.64M
Rd Expense Q3 2025 · Sep 30, 2025 $9.59M
Rd Expense Q3 2025 · Sep 30, 2025 $29.51M
Rd Expense Q3 2025 · Sep 30, 2024 $8.07M
Rd Expense Q3 2025 · Sep 30, 2024 $22.21M
Net Income Q3 2025 · Sep 30, 2025 −$13.26M
Net Income Q3 2025 · Sep 30, 2025 −$40.13M
Net Income Q3 2025 · Jun 30, 2025 −$14.96M
Net Income Q3 2025 · Mar 31, 2025 −$11.91M
Net Income Q3 2025 · Sep 30, 2024 −$11.22M
Net Income Q3 2025 · Sep 30, 2024 −$31.83M
Net Income Q3 2025 · Jun 30, 2024 −$9.51M
Net Income Q3 2025 · Mar 31, 2024 −$11.1M
Operating Income Q3 2025 · Sep 30, 2025 −$14.76M
Operating Income Q3 2025 · Sep 30, 2025 −$45.47M
Operating Income Q3 2025 · Sep 30, 2024 −$12.33M
Operating Income Q3 2025 · Sep 30, 2024 −$34.84M